Water Tower Research Publishes Initiation of Coverage Report on LifeVantage Corporation Titled, “Initiating Coverage: Believe Recent Return to Growth to be Sustainable”

November 29, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on LifeVantage Corporation (NASDAQ: LFVN) titled, “Initiating Coverage: Believe Recent Return to Growth to be Sustainable”. The report can be accessed here.

LifeVantage is a world leader in using nutrigenomics to activate a healthy body, mind, and mood with science-backed products that include unique combinations of naturally occurring compounds. The company activates financial, social, and community wellness by using a direct selling model to offer its premium-quality supplements, energy, and skincare products through a connected network of independent consultants around the globe.

LFVN has moved up 83% so far in 2023. Despite this, LFVN is still trading at only 10.0x our CY24 EPS estimate of $0.63, which is slightly below the average of its direct selling peers of about 11.5x. However, we note that the peer group averages are being held down by the historically low prospective P/E ratios the market currently assigns to Herbalife Nutrition (4.0x) and Nu Skin Enterprises (7.9x), two bellwether global direct sellers that have been caught up in the turbulence the channel is currently experiencing.

About Water Tower Research 

Water Tower Research is modernizing Investor Relations through research-driven communications and Investor Engagement. Sound investment research begins with good information. At WTR, we help companies and investors connect by creating expert information flow and strategies that are the foundation of a successful modern investor relations platform. Our analysts and capital markets professionals bring decades of unrivaled Wall Street experience and insight to a new digital world of investor communications and engagement. Our research and investor content is distributed across traditional research aggregators like Bloomberg, FactSet, etc., proprietary direct distribution lists, social media, search engines, and our website. As a result, every institutional and retail investor has equal access to our high-quality company research. Our mission is to help companies take control of their IR program and proactively reach investors while bringing investors a consistent flow of quality information to help them understand our clients’ businesses, industries, and the investment opportunities they present.

Tags: wellness, activation, Protandim, TrueScience, Direct Selling, Nutrigenomics